Idiopathic multicentric Castleman disease (iMCD) is a rare, life-threatening lymphoproliferative disorder characterized by systemic inflammation, constitutional symptoms, and dysregulated cytokine production, particularly interleukin-6 (IL-6) [1-4]. This evidence concerns the gene IL6 and lymphoproliferative syndrome.